Answers are grounded in this paper and cite their sources.
Solubility has always been a challenge for the pharmaceutical fraternity owing to the dependency of bioavailability on the same. The objective of the current work was to improve the aqueous solubility of a BCS class II anti-retroviral drug, ritonavir, by using melt technology via the Pastillation technique. EUDRAGIT® EPO was chosen as representative of amorphous high molecular weight synthetic functional polymers. Ritonavir with EUDRAGIT® EPO and other plasticization aid was proces
No takes yet. Share an insight, caveat, or question.
Guha et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: